Estimates Revisions Ipca Laboratories Limited Bombay S.E.
Stocks
IPCALAB
INE571A01038
Pharmaceuticals
|
Market Closed -
Bombay S.E.
03:32:20 28/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1,950.75 INR | -0.40% |
|
+2.66% | +36.99% |
| 14/08 | Ipca Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026 | |
| 13/08 | Ipca Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- IPCALAB Stock
- IPCALAB Stock
- Consensus Ipca Laboratories Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
